SARS-CoV-2 Viral Load is Associated with Increased Disease Severity and Mortality
Jesse Fajnzylber(Brigham and Women's Hospital), Jonathan Z. Li(Brigham and Women's Hospital), Nikolaus Jilg(Harvard University), Bruce D. Walker(Howard Hughes Medical Institute), Keith T. Flaherty(Cancer Research Center), Kathryn Hall(Harvard University), Edward A. Ryan(Harvard University), James Regan(Brigham and Women's Hospital), Alexandra Rosenthal(Brigham and Women's Hospital), Dusan Hanidziar(Harvard University), Kendyll Coxen(Brigham and Women's Hospital), Michael Dougan(Harvard University), Katrina Armstrong(Columbia University), Caroline Atyeo(Ragon Institute of MGH, MIT and Harvard), Athe Tsibris(Brigham and Women's Hospital), Daniel R. Kuritzkes(Brigham and Women's Hospital), Galit Alter(Ragon Institute of MGH, MIT and Harvard), Stephanie Fischinger(Leiden University), Alicja Piechocka‐Trocha(Harvard University), Andrew T. Chan(Harvard University), Xu G. Yu(Massachusetts General Hospital), Rebecca M. Baron(Brigham and Women's Hospital), Daniel Worrall(Harvard University), Colline Wong(Brigham and Women's Hospital), Lindsey R. Baden(Brigham and Women's Hospital), Yijia Li(Brigham and Women's Hospital), Rida Chishti(Brigham and Women's Hospital), Elizabeth Gillespie(University of Colorado Hospital), Françoise Giguel(Harvard University), Heather Corry(Brigham and Women's Hospital)
Cited by 51
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
|Science|2016|5.3k
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
|New England Journal of Medicine|2010|3.5k
Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study
|The Lancet Public Health|2020|2.3k